Cargando…

Serial MRI Features of Canine GM1 Gangliosidosis: A Possible Imaging Biomarker for Diagnosis and Progression of the Disease

GM1 gangliosidosis is a fatal neurodegenerative lysosomal storage disease caused by an autosomal recessively inherited deficiency of β-galactosidase activity. Effective therapies need to be developed to treat the disease. In Shiba Inu dogs, one of the canine GM1 gangliosidosis models, neurological s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hasegawa, Daisuke, Yamato, Osamu, Nakamoto, Yuya, Ozawa, Tsuyoshi, Yabuki, Akira, Itamoto, Kazuhito, Kuwabara, Takayuki, Fujita, Michio, Takahashi, Kimimasa, Mizoguchi, Shunta, Orima, Hiromitsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific World Journal 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334264/ https://www.ncbi.nlm.nih.gov/pubmed/22536126 http://dx.doi.org/10.1100/2012/250197

Ejemplares similares

In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses
por: Kohyama, Moeko, et al.
Publicado: (2016)

Skeletal radiographic manifestations of GM2 gangliosidosis variant 0 (Sandhoff disease) in two Japanese domestic cats
por: Yu, Yoshihiko, et al.
Publicado: (2022)

GM1 gangliosidosis in a Japanese domestic cat: a new variant identified in Hokkaido, Japan
por: UENO, Hiroshi, et al.
Publicado: (2015)

Molecular epidemiology of canine GM1 gangliosidosis in the Shiba Inu breed in Japan: relationship between regional prevalence and carrier frequency
por: Uddin, Mohammad M, et al.
Publicado: (2013)

Magnetic Resonance Findings of the Corpus Callosum in Canine and Feline Lysosomal Storage Diseases
por: Hasegawa, Daisuke, et al.
Publicado: (2013)

Carrier Rate and Mutant Allele Frequency of GM1 Gangliosidosis in Miniature Shiba Inus (Mame Shiba): Population Screening of Breeding Dogs in Japan
por: Pervin, Shahnaj, et al.
Publicado: (2022)

Genetics and Therapies for GM2 Gangliosidosis
por: Cachón-González, María Begoña, et al.
Publicado: (2018)

GM1 Gangliosidosis: Mechanisms and Management
por: Rha, Allisandra K, et al.
Publicado: (2021)

Real-Time PCR Genotyping Assay for GM2 Gangliosidosis Variant 0 in Toy Poodles and the Mutant Allele Frequency in Japan
por: RAHMAN, Mohammad Mahbubur, et al.
Publicado: (2013)

GM1 Gangliosidosis—A Mini-Review
por: Nicoli, Elena-Raluca, et al.
Publicado: (2021)

GM1gangliosidosis: Clinical and radiological clue to diagnosis
por: Suthar, Renu, et al.
Publicado: (2012)

Animal models of GM2 gangliosidosis: utility and limitations
por: Lawson, Cheryl A, et al.
Publicado: (2016)

Characterization of glycan substrates accumulating in GM1 Gangliosidosis
por: Lawrence, Roger, et al.
Publicado: (2019)

GM1‐Gangliosidosis Type III Associated Parkinsonism
por: Kaiyrzhanov, Rauan, et al.
Publicado: (2021)

Wishbone Sign in GM1 Type III Gangliosidosis
por: Agarwal, Ayush, et al.
Publicado: (2023)

Biochemical Correction of GM2 Ganglioside Accumulation in AB-Variant GM2 Gangliosidosis
por: Deschenes, Natalie M., et al.
Publicado: (2023)

Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis
por: Allende, Maria L., et al.
Publicado: (2023)

Canine GM2‐Gangliosidosis Sandhoff Disease Associated with a 3‐Base Pair Deletion in the HEXB Gene
por: Wang, P., et al.
Publicado: (2017)

Neuroradiological findings in GM2 gangliosidosis variant B1
por: Bano, Shahina, et al.
Publicado: (2011)

Clinical findings in Brazilian patients with adult GM1 gangliosidosis
por: Giugliani, Luciana, et al.
Publicado: (2019)

Progressive dystonia as a presenting manifestation of GM1 gangliosidosis
por: Mehta, Sahil, et al.
Publicado: (2019)

Late-infantile GM1 gangliosidosis: A case report
por: Noh, Eu Seon, et al.
Publicado: (2022)

Myelin Abnormalities in the Optic and Sciatic Nerves in Mice With GM1-Gangliosidosis
por: Heinecke, Karie A., et al.
Publicado: (2015)

GM2 Gangliosidosis in Shiba Inu Dogs with an In‐Frame Deletion in HEXB
por: Kolicheski, A., et al.
Publicado: (2017)

Extensive Mongolian Spots in a Hypotonic Infant with GM1 Gangliosidosis
por: Ranjan, Suprabhat, et al.
Publicado: (2018)

Positioning Head Tilt in Canine Lysosomal Storage Disease: A Retrospective Observational Descriptive Study
por: Tamura, Shinji, et al.
Publicado: (2021)

GM1 GANGLIOSIDOSIS ASSOCIATED WITH NEONATAL-ONSET OF DIFFUSE ECCHYMOSES AND MONGOLIAN SPOTS
por: Dweikat, Imad, et al.
Publicado: (2011)

Genetic Analysis of Undiagnosed Juvenile GM1-Gangliosidosis by Microarray and Exome Sequencing
por: Bouhouche, Ahmed, et al.
Publicado: (2018)

A pentasaccharide for monitoring pharmacodynamic response to gene therapy in GM1 gangliosidosis
por: Kell, Pamela, et al.
Publicado: (2023)

Pre-diagnosing and managing patients with GM1 gangliosidosis and related disorders by the evaluation of GM1 ganglioside content
por: Tonin, Rodolfo, et al.
Publicado: (2019)

Retrospective epidemiological study of canine epilepsy in Japan using the International Veterinary Epilepsy Task Force classification 2015 (2003–2013): etiological distribution, risk factors, survival time, and lifespan
por: Hamamoto, Yuji, et al.
Publicado: (2016)

Cysts in White Matter: A Novel Neuroimaging Finding in Infantile GM1 Gangliosidosis
por: Kamate, Mahesh
Publicado: (2018)

Single Institutional Experience with GM1 Gangliosidosis: Clinical and Laboratory Results of 14 Patients
por: Akar, Halil Tuna, et al.
Publicado: (2022)

GM1‐gangliosidosis: The caregivers' assessments of symptom impact and most important symptoms to treat
por: Bingaman, Amanda, et al.
Publicado: (2022)

Therapeutic Potential of Intracerebroventricular Replacement of Modified Human β-Hexosaminidase B for GM2 Gangliosidosis
por: Matsuoka, Kazuhiko, et al.
Publicado: (2011)

Cerebellar atrophy on top of motor neuron compromise as indicator of late-onset GM2 gangliosidosis
por: Hölzer, Hans Thomas, et al.
Publicado: (2021)

Therapeutic advantages of combined gene/cell therapy strategies in a murine model of GM2 gangliosidosis
por: Sala, Davide, et al.
Publicado: (2022)

Hematopoietic stem cell gene therapy ameliorates CNS involvement in murine model of GM1-gangliosidosis
por: Tsunogai, Toshiki, et al.
Publicado: (2022)

Hematopoietic stem cell gene therapy ameliorates CNS involvement in murine model of GM1-gangliosidosis
por: Tsunogai, Toshiki, et al.
Publicado: (2022)

Synthesis of a New β-Galactosidase Inhibitor Displaying Pharmacological Chaperone Properties for GM1 Gangliosidosis
por: Clemente, Francesca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ssti6j06odptnckidafnsu0ivm